Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ST3GAL6 |
| Upstream (Parents) |
|---|
| (<<) ABCA6 → ST3GAL6 |
| (<<) MAOB → ST3GAL6 |
| (<<) KCNJ8 → ST3GAL6 |
| (<<) TMEM45A → ST3GAL6 |
| Downstream (Children) |
|---|
| ST3GAL6 → CDC37P1 (>>) |
| ST3GAL6 → LY6E (>>) |
| ST3GAL6 → CADM1 (>>) |
| ST3GAL6 → IL17RC (>>) |
| ST3GAL6 → NTF3 (>>) |
| ST3GAL6 → GABARAPL1 (>>) |
| ST3GAL6 → PRR4///PRH2///PRH1///PRB4///PRB1 (>>) |
| ST3GAL6 → ARHGAP29 (>>) |
| ST3GAL6 → STOML1 (>>) |
| ST3GAL6 → CASP5 (>>) |
| ST3GAL6 → AP1G2 (>>) |
| ST3GAL6 → FKBP1B (>>) |
| ST3GAL6 → SLC43A3 (>>) |
| ST3GAL6 → OBSL1 (>>) |
| ST3GAL6 → RBP1 (>>) |
| ST3GAL6 → GNAI1 (>>) |
| ST3GAL6 → SPTLC3 (>>) |
| ST3GAL6 → KCNJ8 (>>) |
| ST3GAL6 → ADD3 (>>) |
| ST3GAL6 → TMEM45A (>>) |
